ANI Pharmaceuticals, Inc.
ANIPDrug Manufacturers - Specialty & Generic
$73.16+2.02%As of Oct 29vs prior close
- Market cap
- $1.7B
- P/E (TTM)
- 15.1×
- P/E (FY1)
- 7.9×
- From 52W high
- −22.57%
- EPS (LTM)
- $4.60
- Revenue (LTM)
- $978.4M
- Net margin
- 11.07%
Nomior Score
62
Anchored CompounderSpeculativeTop 23% of the scored universe
Growth63
Quality72
Value85
Momentum6
Resilience63
Growth
+23.87%revenue a year over 9 fiscal years
YE16 $128.6MLTM $978.4M
Connections
Revenue to profitQ2 YE26
9% of revenue became net profit, up 5 pts on a year.
Who owns it
2funds